Now that's out of the way, we shouldn't get another one the next time the share price re-rates on high volume.Share holder interest is definitely increasing here, and with bugger all sellers, the only way is up!Strap in!
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status
